Search

everythinglearnresearchcommunity

for

Search:↓

The book "Eye and Skin Disease" is recommended for its detailed coverage of the connection between eye and skin conditions.

Substances from Chinese medicines show promise for immune support and disease prevention, but the way they are processed affects their effectiveness.

New treatments for hair loss show promise, but more research is needed to confirm their safety and effectiveness.

DCP therapy causes side effects like weakness, flushing, headaches, and taste changes, but less frequently causes hypertension and diabetes.

Spironolactone, a heart and liver drug, has new uses including cancer treatment, viral infection prevention, and skin condition improvement.

Alopecia Areata has no cure, treatments are limited, and the condition often recurs, but new therapies like JAK inhibitors show promise.

The document concludes that managing skin conditions during pregnancy is important and requires specialized care.

Older obese women with PCOS have higher cardiovascular and metabolic risks despite lower androgen levels.

Women with nonclassic congenital adrenal hyperplasia experience more sexual dysfunction and distress.

Tofacitinib is a promising treatment for severe alopecia areata, with many patients experiencing complete or partial hair regrowth.

Baricitinib effectively regrows hair in most people with severe alopecia, especially those with patchy hair loss, but hair may fall out again if treatment stops.

Some women with excess hair growth have a hormone condition that can't be diagnosed by blood or urine tests alone.

Kids with alopecia areata had lower vitamin D levels than healthy kids.

PRP therapy effectively treats alopecia areata and atrophic acne scars.

Mixing calcipotriol with a steroid is almost as effective as using a steroid alone for alopecia areata and has fewer side effects.

The Polish medical societies have redefined metabolic syndrome and recommend lifestyle changes, certain medications, and possibly bariatric surgery for treatment. They also discuss managing related health conditions.

A two-step method was created in 2015 to make more cells that help with hair growth, but they need to be combined with other cells for 4 days to actually form new hair.

Different sizes of keratin peptides can strengthen hair, with smaller ones possibly increasing volume and larger ones repairing damage.

Baricitinib helps regrow hair in adults with severe alopecia better than a placebo and is approved for treatment, but long-term effects are still unknown.

An 8-year-old with severe hair loss regrew all hair after six months of tofacitinib treatment.

PCOS in lean women is a serious health condition with implications beyond fertility, affecting metabolism and increasing cardiovascular disease risk.

Baricitinib significantly improved hair regrowth and skin condition in a 14-year-old with alopecia areata and atopic dermatitis.

Combining CGF and microneedling with betamethasone effectively treats resistant alopecia areata.

Baricitinib maintains significant hair regrowth in severe alopecia areata over three years.

Baricitinib 4 mg is effective and safe for treating severe alopecia areata.

Tofacitinib is an effective and safe treatment for alopecia areata.

Tofacitinib was effective for severe, treatment-resistant hair loss without side effects.

Measuring bald patch size can help grade hair loss severity, with photograph-based evaluation being more reliable.

Minoxidil-dutasteride tattooing can potentially help regrow hair, especially in men who already have some thin hair.

A young Saudi girl with uncontrolled type 1 diabetes and hypothyroidism had two rare conditions, Mauriac syndrome and Van Wyk–Grumbach syndrome.